Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC.
Malene NielsenMartin GraversenSigne Bremholm EllebækThomas Kielsgaard KristensenClaus FristrupPer PfeifferMichael Bau MortensenSönke DetlefsenPublished in: Journal of clinical pathology (2020)
PIPAC induces histological response in the majority of patients with PM-PC. KRAS mutation can be found in PM-PC after PIPAC at a frequency similar to the primaries. NGS may be used to detect predictive mutations in PM-PC of various origins, also when only post-PIPAC QBs or PFs are available.